» Articles » PMID: 33978571

Structural Basis for Allosteric Control of the SERCA-Phospholamban Membrane Complex by Ca and Phosphorylation

Overview
Journal Elife
Specialty Biology
Date 2021 May 12
PMID 33978571
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Phospholamban (PLN) is a mini-membrane protein that directly controls the cardiac Ca-transport response to β-adrenergic stimulation, thus modulating cardiac output during the fight-or-flight response. In the sarcoplasmic reticulum membrane, PLN binds to the sarco(endo)plasmic reticulum Ca-ATPase (SERCA), keeping this enzyme's function within a narrow physiological window. PLN phosphorylation by cAMP-dependent protein kinase A or increase in Ca concentration reverses the inhibitory effects through an unknown mechanism. Using oriented-sample solid-state NMR spectroscopy and replica-averaged NMR-restrained structural refinement, we reveal that phosphorylation of PLN's cytoplasmic regulatory domain signals the disruption of several inhibitory contacts at the transmembrane binding interface of the SERCA-PLN complex that are propagated to the enzyme's active site, augmenting Ca transport. Our findings address long-standing questions about SERCA regulation, epitomizing a signal transduction mechanism operated by posttranslationally modified bitopic membrane proteins.

Citing Articles

SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established.

Shooshtarian A, OGallagher K, Shah A, Zhang M Heart Fail Rev. 2025; .

PMID: 39843817 DOI: 10.1007/s10741-025-10487-1.


Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium.

Cleary S, Teng A, Kongmeneck A, Fang X, Phillips T, Cho E J Biol Chem. 2024; 301(2):108118.

PMID: 39710323 PMC: 11791128. DOI: 10.1016/j.jbc.2024.108118.


β-adrenergic regulation of Ca signaling in heart cells.

Yang B, Wang S, Yang H Biophys Rep. 2024; 10(5):274-282.

PMID: 39539286 PMC: 11554573. DOI: 10.52601/bpr.2024.240906.


Probing the formation of a hetero-dimeric membrane transport complex with dual and mutagenesis.

Rathod N, Lemieux M, Chipot C, Roux B, Young H Chem Sci. 2024; .

PMID: 39156929 PMC: 11322925. DOI: 10.1039/d4sc02915a.


Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition.

Weber D, Reddy U, Robia S, Veglia G Biochim Biophys Acta Biomembr. 2024; 1866(7):184370.

PMID: 38986894 PMC: 11457527. DOI: 10.1016/j.bbamem.2024.184370.


References
1.
Akin B, Chen Z, Jones L . Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state. J Biol Chem. 2010; 285(37):28540-52. PMC: 2937880. DOI: 10.1074/jbc.M110.151779. View

2.
Toyoshima C, Nomura H, Tsuda T . Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues. Nature. 2004; 432(7015):361-8. DOI: 10.1038/nature02981. View

3.
Norimatsu Y, Hasegawa K, Shimizu N, Toyoshima C . Protein-phospholipid interplay revealed with crystals of a calcium pump. Nature. 2017; 545(7653):193-198. DOI: 10.1038/nature22357. View

4.
Masterson L, Yu T, Shi L, Wang Y, Gustavsson M, Mueller M . cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban. J Mol Biol. 2011; 412(2):155-64. PMC: 3513267. DOI: 10.1016/j.jmb.2011.06.041. View

5.
Li J, Xiong Y, Bigelow D, Squier T . Phospholamban binds in a compact and ordered conformation to the Ca-ATPase. Biochemistry. 2004; 43(2):455-63. DOI: 10.1021/bi035424v. View